MEMBERSHIP BENEFITS...
- Discounted isirv conference rates
- Opportunities to network and connect with world experts in the field of respiratory virus diseases
NEWS & EVENTS
News
Past Events
CONTACT
 |
Given the ongoing COVID-19 restrictions, the RSV2020 conference originally planned for September 2020 has been postponed until 2022. RSV2022 will be hosted at the ICC Waterfront, an award-winning venue in Belfast, N.Ireland.
|
|
In the meantime, the RSV Webinar Series, held February 2021, provided research updates to the RSV Community. Webinar recordings can be accessed via the RSV Webinar Programme - key topics below:
1 February 2021 - Epidemiology and Spectrum of RSV Disease Keynote: Prof Harish Nair 8 February 2021 - RSV Molecular Biology Keynote: Prof Carolina Lopez 15 February 2021 - RSV Pathogenesis and Immunity Keynote: Prof Peter Openshaw 22 February 2021 - RSV Vaccines and Therapies Keynote: Dr Barney S. Graham |
|
The 10th edition of the Options for the Control of Influenza conference in Singapore ended on 1 September 2019.
The 11th meeting in the series, OPTIONS XI, will be held in Milan, Italy, August 2022.
Attendance Certificates can be requested from secretariat@isirv.org
OPTIONS X Programme
An Influenza update from the WHO can be found here.
The recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season can be found here.
Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in human vaccines is here.
Information and links to other sources of information on this evolving situation is available in the news section.
We are delighted to announce the winners of this award:
Dr Kirsty Short, School of Chemistry and Molecular Biosciences, The University of Queensland, Australia.
Dr Raffael Nachbagauer, Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York, USA.
This prestigious award is for outstanding early career investigators in the field of respiratory viruses.
Both Drs Short and Nachbagauer will be invited to deliver a keynote lecture at an appropriate isirv meeting, but in the interim, they have kindly agreed to deliver a webinar based on their research (further details to be announced)
In mid-2017, the International Respiratory Syncytial Virus Society (IRSVS) became a special interest group of isirv. The IRSVS is a global independent group of RSV professionals, with members from all continents working on all research fronts. The IRSVS’s goal is to ensure that there is a succession of venues to share scientific information and accelerate the development of strategies to reduce the impact of RSV infection. Read more...
This conference addressed new immunological assays and immune correlates of protection needed to estimate the immunogenicity and protective efficacy of next generation influenza vaccines currently being developed.Visit the website
Final Programme here. See Meeting report
The ISIRV Journal, Influenza and other Respiratory Viruses, is now published in an online only format. No printed issue will be produced but authors will still be able to order offprints of their own articles. ISIRV members will receive a 10% discount for articles submitted.
Contact membership@isirv.org for the code.